News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
SABBY MANAGEMENT, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 2.6% stake in AGM Group Holdings Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Cingulate Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Context Therapeutics Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.6% stake in Tantech Holdings Ltd |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 3.4% stake in Heartbeam, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Recon Technology, Ltd. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 3.8% stake in Bit Digital, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.4% stake in Virpax Pharmaceuticals, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in PharmaCyte Biotech, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5.2% stake in Cocrystal Pharma, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.3% stake in Pulmatrix, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Rebus Holdings, Inc. |
| 01/05/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.4% stake in Skye Bioscience, Inc. |
| 01/05/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Reviva Pharmaceuticals Holdings, Inc. |
| 01/05/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 6.4% stake in Pulmatrix, Inc. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Supercom Ltd. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Bluejay Diagnostics, Inc. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in BioRestorative Therapies, Inc., |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 10% stake in Recon Technology, Ltd. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 7.5% stake in Virpax Pharmaceuticals, Inc. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Aditxt, Inc. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 6.1% stake in PharmaCyte Biotech, Inc. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 2.6% stake in Red Cat Holdings, Inc. |
| 01/04/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in ENGlobal Corporation |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.3% stake in 1847 Goedeker Inc. |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5.9% stake in Cocrystal Pharma, Inc. |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Bit Brother Ltd. |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Iterum Therapeutics plc |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in DSS, Inc. |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Document Security Systems, Inc. |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Dogness Corporation |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Titan Pharmaceuticals, Inc. |
| 01/03/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.3% stake in Orbital Energy Group, Inc. |
| 01/08/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|